BioOptics Stock Watch
Markets
Stocks
Funds
Sectors
Tools
Current Price
Components
Dashboard
Latest News
Search InvestCenter
Recent Quotes
My Watchlist
Indicators
BioOptics Stock Watch (CIX: BOSW)
4,432.50   UNCHANGED
Streaming Delayed Price  /  Updated: 8:10 PM EDT, Jul 25, 2014  /  Add to My Watchlist      
View: Quote Components News
Index Value
Chart for (: )
 
Intraday
1 Week
1 Month
3 Month
1 Year
  
Compare to:
Price 4432.50
Volume 0
Open 4428.58
Prev. Close 4432.50
Change
+0.00
% Change
0.00%
Today's Range 4418.40 - 4464.20
52wk Range 2458.56 - 4541.62
Performance
YTD
+1350.99 (43.84%)
1 Month
+114.28 (2.65%)
3 Month
+153.36 (3.58%)
6 Month
+1110.29 (33.42%)
1 Year
+1886.37 (74.09%)
Top News
More News
Syneron Announces Investor Meeting Focused on UltraShape U.S. Launch Update on September 17, 2014
July 25, 2014
from PR Newswire
Earnings and Equity Performance Review -- Allergan
July 25, 2014
Editor Note: For more information about this release, please scroll to bottom Read More
from PR Newswire
More News
More News
Newport Corporation Enters Into Agreement To Acquire Fiber Laser Company V-Gen Ltd.
July 24, 2014
Acquisition Expected to Be Accretive Immediately and Will Enhance Newport's Fiber Laser Capabilities for Micromachining Applications Read More
from PR Newswire
IRIDEX Announces Second Quarter 2014 Conference Call and Release Date
July 24, 2014
from PR Newswire
Spectranetics Achieves Second Quarter 2014 Revenue of $43.6 Million
July 24, 2014
2014 Outlook Revised for AngioScore Acquisition Read More
from GlobeNewswire News Releases
Allergan Announces OZURDEX® (dexamethasone 700 mcg intravitreal implant in applicator) Receives European Positive Opinion for the Treatment of Diabetic Macular Edema
July 25, 2014
from Business Wire News Releases
Valeant Pharmaceuticals Files An Official Complaint With The Autorite Des Marches Financiers About Allergan's False And Misleading Statements
July 24, 2014
from PR Newswire
Cynosure Receives Expanded FDA Clearance to Market PicoSure™ for Treatment of Acne Scars
July 24, 2014
Demonstrates Ability of FOCUS Lens Array Technology to Treat Additional High-Volume Indications Read More
from PR Newswire
Newport Corporation To Present At Third Annual Needham & Co. Advanced Industrial Technologies Conference
July 24, 2014
from PR Newswire
Allergan gets EU recommendation on new use of eye drug
July 25, 2014
July 25 (Reuters) - Allergan Inc, known best for its Botox wrinkle treatment, said on Friday that European Union regulators had recommended use of its eye drug Ozurdex be extended to treat patients... Read More
from Reuters: Company News
Allergan (AGN) Receives Positive Recommendation from EMA CHMP for OZURDEX Marketing Authorization
July 25, 2014
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=9690093 for the full story. Read More
from StreetInsider.com News Articles
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Six Financial
Postage Rates Bots go here
toggle footer display